Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 8 de 8
1.
Clin Exp Pharmacol Physiol ; 47(2): 199-212, 2020 02.
Article En | MEDLINE | ID: mdl-31612525

Naegleria fowleri, a thermophilic flagellate amoeba known as a "brain-eating" amoeba, is the aetiological agent of a perilous and devastating waterborne disease known as primary amoebic meningoencephalitis (PAM), both in humans as well as in animals. PAM is a rare but fatal disease affecting young adults all around the world, particularly in the developed world but recently reported from developing countries, with 95%-99% mortality rate. Swimmers and divers are at high risk of PAM as the warm water is the most propitious environment adapted by N. fowleri to cause this infection. Infective amoeba in the trophozoite phase enter the victim's body through the nose, crossing the cribriform plate to reach the human brain and cause severe destruction of the central nervous system (CNS). The brain damage leads to brain haemorrhage and death occurs within 3-7 days in undiagnosed cases and maltreated cases. Though the exact pathogenesis of N. fowleri is still not known, it has exhibited two primary mechanisms, contact-independent (brain damage through different proteins) and contact-dependent (brain damage through surface structures food cups), that predominantly contribute to the pathogen invading the host CNS. For the management of this life-threatening infection different treatment regimens have been applied but still the survival rate is only 5% which is ascribed to its misdiagnosis, as the PAM symptoms closely resembled bacterial meningitis. The main objectives of this review article are to compile data to explore the sources and routes of N. fowleri infection, its association in causing PAM along with its pathophysiology; latest techniques used for accurate diagnosis, management options along with challenges for Pakistan to control this drastic disorder.


Brain/parasitology , Central Nervous System Protozoal Infections/drug therapy , Central Nervous System Protozoal Infections/prevention & control , Disease Management , Naegleria fowleri/isolation & purification , Animals , Anti-Infective Agents/pharmacology , Anti-Infective Agents/therapeutic use , Brain/drug effects , Brain/metabolism , Central Nervous System Protozoal Infections/metabolism , Humans , Naegleria fowleri/drug effects , Naegleria fowleri/metabolism , Olfactory Mucosa/drug effects , Olfactory Mucosa/metabolism , Olfactory Mucosa/parasitology
2.
Parasite Immunol ; 41(8): e12631, 2019 08.
Article En | MEDLINE | ID: mdl-31077592

Free-living amoeba, Naegleria fowleri, destroys target cells through contact-dependent mechanisms, such as phagocytosis and/or trogocytosis. A previous experiment showed that the nf-actin gene consisted of 1.2 kbp, produced a 50.1 kDa recombinant protein (Nf-actin), and was localized on the cytoskeleton, pseudopodia and amoebastome. In this study, cellular characterization of the nf-actin gene concerned with contact-dependent mechanisms in N fowleri was performed. The nf-actin gene was amplified from a gene-cloned vector, pEXQP5-T7/NT TOPO. The nf-actin gene was introduced into the Ubi-pEGFP-C2 vector, and Ubi-pEGFP-C2/nf-actin was transfected into N fowleri trophozoites. Strong GFP fluorescence was detected in N fowleri trophozoites transfected with Ubi-pEGFP-C2/nf-actin. Expression of EGFP-Nf-actin protein was detected by Western blot analysis. The nf-actin-overexpressing N fowleri showed significantly increased adhesion activity against extracellular matrix components, fibronectin, collagen I and fibrinogen, compared with wild-type N fowleri. Moreover, nf-actin-overexpressing N fowleri showed increased phagocytic activity and cytotoxicity in comparison with wild-type N fowleri. In summary, the overexpressed nf-actin gene has an important function in ability to increase cell adhesion, cytotoxicity and phagocytosis by N fowleri.


Actins/metabolism , Central Nervous System Protozoal Infections/parasitology , Naegleria fowleri/metabolism , Actins/genetics , Animals , CHO Cells , Central Nervous System Protozoal Infections/genetics , Central Nervous System Protozoal Infections/metabolism , Cloning, Molecular , Cricetinae , Cricetulus , Fibronectins/genetics , Fibronectins/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Naegleria fowleri/genetics , Naegleria fowleri/growth & development , Protein Transport , Trophozoites/genetics , Trophozoites/growth & development , Trophozoites/metabolism
3.
J Eukaryot Microbiol ; 65(6): 804-819, 2018 11.
Article En | MEDLINE | ID: mdl-29655298

Naegleria fowleri causes a fatal disease known as primary amoebic meningoencephalitis. This condition is characterized by an acute inflammation that originates from the free passage of peripheral blood cells to the central nervous system through the alteration of the blood-brain barrier. In this work, we established models of the infection in rats and in a primary culture of endothelial cells from rat brains with the aim of evaluating the activation and the alterations of these cells by N. fowleri. We proved that the rat develops the infection similar to the mouse model. We also found that amoebic cysteine proteases produced by the trophozoites and the conditioned medium induced cytopathic effect in the endothelial cells. In addition, N. fowleri can decrease the transendothelial electrical resistance by triggering the destabilization of the tight junction proteins claudin-5, occludin, and ZO-1 in a time-dependent manner. Furthermore, N. fowleri induced the expression of VCAM-1 and ICAM-1 and the production of IL-8, IL-1ß, TNF-α, and IL-6 as well as nitric oxide. We conclude that N. fowleri damaged the blood-brain barrier model by disrupting the intercellular junctions and induced the presence of inflammatory mediators by allowing the access of inflammatory cells to the olfactory bulbs.


Blood-Brain Barrier/parasitology , Central Nervous System Protozoal Infections/metabolism , Endothelial Cells/metabolism , Naegleria fowleri/metabolism , Naegleria fowleri/pathogenicity , Tight Junction Proteins/metabolism , Animals , Central Nervous System Protozoal Infections/parasitology , Central Nervous System Protozoal Infections/pathology , Claudin-5/metabolism , Cysteine Proteases/metabolism , Cytokines/metabolism , Disease Models, Animal , Inflammation , Intercellular Adhesion Molecule-1/metabolism , Interleukin-1beta/metabolism , Interleukin-8/metabolism , Male , Meningoencephalitis/parasitology , Meningoencephalitis/pathology , Mice , Mucous Membrane/parasitology , Mucous Membrane/pathology , Occludin/metabolism , Rats , Rats, Wistar , Trophozoites/metabolism , Tumor Necrosis Factor-alpha/metabolism , Turbinates/pathology , Vascular Cell Adhesion Molecule-1/metabolism , Zonula Occludens-1 Protein/metabolism
4.
Sci Rep ; 7(1): 8454, 2017 08 16.
Article En | MEDLINE | ID: mdl-28814754

Visceral leishmaniasis (VL) is a systemic disease with multifaceted clinical manifestations, including neurological signs, however, the involvement of the nervous system during VL is underestimated. Accordingly, we investigated both brain infection and inflammation in a mouse model of VL. Using bioluminescent Leishmania donovani and real-time 2D-3D imaging tools, we strikingly detected live parasites in the brain, where we observed a compartmentalized dual-phased inflammation pattern: an early phase during the first two weeks post-infection, with the prompt arrival of neutrophils and Ly6Chigh macrophages in an environment presenting a variety of pro-inflammatory mediators (IFN-γ, IL-1ß, CXCL-10/CXCR-3, CCL-7/CCR-2), but with an intense anti-inflammatory response, led by IL-10; and a re-inflammation phase three months later, extremely pro-inflammatory, with novel upregulation of mediators, including IL-1ß, TNF-α and MMP-9. These new data give support and corroborate previous studies connecting human and canine VL with neuroinflammation and blood-brain barrier disruption, and conclusively place the brain among the organs affected by this parasite. Altogether, our results provide convincing evidences that Leishmania donovani indeed infects and inflames the brain.


Central Nervous System Protozoal Infections/parasitology , Encephalitis/parasitology , Leishmania donovani/physiology , Leishmaniasis/parasitology , Animals , Central Nervous System Protozoal Infections/metabolism , Cytokines/metabolism , Encephalitis/metabolism , Female , Inflammation Mediators/metabolism , Leishmania donovani/genetics , Leishmania donovani/metabolism , Leishmaniasis/metabolism , Leishmaniasis, Visceral/metabolism , Leishmaniasis, Visceral/parasitology , Luciferases, Firefly/genetics , Luciferases, Firefly/metabolism , Luminescent Measurements/methods , Macrophages/metabolism , Mice, Inbred BALB C , Neutrophils/metabolism , Time Factors
5.
Arch Pharm Res ; 38(9): 1702-17, 2015 Sep.
Article En | MEDLINE | ID: mdl-26259630

The global emergence of multi-drug resistant bacteria invokes an urgent and imperative necessity for the identification of novel antimicrobials. The general lack of success in progressing novel chemical entities from target-based drug screens have prompted calls for radical and innovative approaches for drug discovery. Recent developments in chemical biology and target deconvolution strategies have revived interests in the utilization of whole-cell phenotypic screens and resulted in several success stories for the discovery and development novel drug candidates and target pathways. In this review, we present and discuss recent chemical biology approaches focusing on the discovery of novel targets and new lead molecules for the treatment of human bacterial and protozoan infections.


Anti-Infective Agents/chemistry , Anti-Infective Agents/therapeutic use , Chemistry, Pharmaceutical/methods , Drug Discovery/methods , Animals , Central Nervous System Protozoal Infections/drug therapy , Central Nervous System Protozoal Infections/metabolism , Humans , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/metabolism
6.
Biomed Res Int ; 2015: 416712, 2015.
Article En | MEDLINE | ID: mdl-26090408

Naegleria fowleri causes acute and fulminant primary amoebic meningoencephalitis. This microorganism invades its host by penetrating the olfactory mucosa and then traveling up the mesaxonal spaces and crossing the cribriform plate; finally, the trophozoites invade the olfactory bulbs. During its invasion, the protozoan obtains nutrients such as proteins, lipids, carbohydrates, and cationic ions (e.g., iron, calcium, and sodium) from the host. However, the mechanism by which these ions are obtained, particularly iron, is poorly understood. In the present study, we evaluated the ability of N. fowleri to degrade iron-binding proteins, including hololactoferrin, transferrin, ferritin, and hemoglobin. Zymography assays were performed for each substrate under physiological conditions (pH 7 at 37°C) employing conditioned medium (CM) and total crude extracts (TCEs) of N. fowleri. Different degradation patterns with CM were observed for hololactoferrin, transferrin, and hemoglobin; however, CM did not cause ferritin degradation. In contrast, the TCEs degraded only hololactoferrin and transferrin. Inhibition assays revealed that cysteine proteases were involved in this process. Based on these results, we suggest that CM and TCEs of N. fowleri degrade iron-binding proteins by employing cysteine proteases, which enables the parasite to obtain iron to survive while invading the central nervous system.


Central Nervous System Protozoal Infections/metabolism , Cysteine Proteases/metabolism , Host-Pathogen Interactions , Iron/metabolism , Proteolysis , Animals , Central Nervous System Protozoal Infections/parasitology , Central Nervous System Protozoal Infections/pathology , Iron-Binding Proteins/metabolism , Lactoferrin/metabolism , Naegleria fowleri/enzymology , Naegleria fowleri/pathogenicity , Olfactory Bulb/metabolism , Olfactory Bulb/pathology , Transferrin/metabolism , Trophozoites/metabolism
7.
J Comp Pathol ; 137(2-3): 102-21, 2007.
Article En | MEDLINE | ID: mdl-17692867

Protozoal meningoencephalitis is considered to be an important cause of mortality in the California sea otter (Enhydra lutris). Thirty nine of 344 (11.3%) California (CA) and Washington state (WA) sea otters examined from 1985 to 2004 had histopathological evidence of significant protozoal meningoencephalitis. The aetiological agents and histopathological changes associated with these protozoal infections are described. The morphology of the actively multiplicative life stages of the organisms (tachyzoites for Toxoplasma gondii and merozoites for Sarcocystis neurona) and immunohistochemical labelling were used to identify infection with S. neurona (n=22, 56.4%), T. gondii (n=5, 12.8%) or dual infection with both organisms (n=12, 30.8%). Active S. neurona was present in all dual infections, while most had only the latent form of T. gondii. In S. neurona meningoencephalitis, multifocal to diffuse gliosis was widespread in grey matter and consistently present in the molecular layer of the cerebellum. In T. gondii meningoencephalitis, discrete foci of gliosis and malacia were more widely separated, sometimes incorporated pigment-laden macrophages and mineral, and were found predominantly in the cerebral cortex. Quiescent tissue cysts of T. gondii were considered to be incidental and not a cause of clinical disease and mortality. Protozoal meningoencephalitis was diagnosed more frequently in the expanding population of WA sea otters (10 of 31, 32.3%) than in the declining CA population (29 of 313, 9.3%). Among sea otters with protozoal meningoencephalitis, those that had displayed neurological signs prior to death had active S. neurona encephalitis, supporting the conclusion that S. neurona is the most significant protozoal pathogen in the central nervous system of sea otters.


Brain/pathology , Brain/parasitology , Central Nervous System Protozoal Infections/veterinary , Otters/parasitology , Sarcocystosis/veterinary , Toxoplasmosis, Animal/pathology , Animals , Antibodies, Protozoan/metabolism , Antigens, Protozoan/metabolism , Brain/metabolism , Cells, Cultured , Central Nervous System Protozoal Infections/metabolism , Central Nervous System Protozoal Infections/pathology , Heart/parasitology , Lung/metabolism , Lung/parasitology , Lung/pathology , Muscle, Skeletal/metabolism , Muscle, Skeletal/parasitology , Muscle, Skeletal/pathology , Myocardium/metabolism , Myocardium/pathology , Retrospective Studies , Sarcocystis/immunology , Sarcocystis/pathogenicity , Sarcocystosis/metabolism , Sarcocystosis/pathology , Toxoplasma/immunology , Toxoplasma/pathogenicity , Toxoplasmosis, Animal/metabolism
8.
J Neuroimmunol ; 142(1-2): 17-30, 2003 Sep.
Article En | MEDLINE | ID: mdl-14512161

Central nervous system (CNS) damage can occur during Trypanosoma cruzi infection, especially in immunosuppressed patients. The enhanced susceptibility of C3H/He mice to CD8-mediated acute meningoencephalitis is associated with higher up-regulation of vascular cell adhesion molecule-1 (VCAM-1) on CNS vascular endothelia than in the less susceptible C57BL/6. Further, in vitro adhesion of activated peripheral blood cells to CNS blood vessels was abrogated by anti-VLA-4 antibodies that also inhibited cell migration into the CNS of T. cruzi-infected mice. Lastly, the reactivation of meningoencephalitis in immunosuppressed chronically infected mice was associated with VCAM-1 up-regulation. Therefore, we hypothesize that VLA-4/VCAM-1 pathway plays a pivotal role in the establishment of T. cruzi-elicited encephalitis.


CD8-Positive T-Lymphocytes/immunology , Central Nervous System Protozoal Infections/immunology , Chagas Disease/immunology , Integrin alpha4beta1/physiology , Meningoencephalitis/immunology , Signal Transduction/immunology , Trypanosoma cruzi/immunology , Vascular Cell Adhesion Molecule-1/physiology , Animals , Antigens, Protozoan/analysis , CD8-Positive T-Lymphocytes/parasitology , Cell Adhesion/immunology , Cell Movement/immunology , Central Nervous System Protozoal Infections/metabolism , Central Nervous System Protozoal Infections/parasitology , Central Nervous System Protozoal Infections/pathology , Chagas Disease/metabolism , Chagas Disease/parasitology , Chagas Disease/pathology , Chronic Disease , Endothelium, Vascular/drug effects , Endothelium, Vascular/immunology , Endothelium, Vascular/parasitology , Endothelium, Vascular/pathology , Female , Genetic Predisposition to Disease , Immunophenotyping , Immunosuppressive Agents/administration & dosage , Integrin alpha4beta1/biosynthesis , Intercellular Adhesion Molecule-1/biosynthesis , Leukocytes, Mononuclear/chemistry , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/parasitology , Meningoencephalitis/metabolism , Meningoencephalitis/parasitology , Meningoencephalitis/pathology , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Recurrence , Vascular Cell Adhesion Molecule-1/biosynthesis
...